CIK 0000899460
- Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133607736
- Phone
- +1 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $256,334
- in 2 filings, $256K under 10b5-1 plans
Net −$256,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-16 | KRESA KENT Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2018-05-16 | Friedman Michael A Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2018-05-16 | CONSIGLIO RONALD J Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2018-05-16 | Shannon James Samuel Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2018-05-16 | Tross Stuart A Corp VP, Chief People Officer | Grant or award · Employee Stock Option (right to buy) | +214,000 | $1.91 | $409K | 214,000 |
| 2018-05-16 | Thomson David Corp VP & General Counsel | Grant or award · Employee Stock Option (right to buy) | +214,000 | $1.91 | $409K | 214,000 |
| 2018-05-16 | McCauley Patrick Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +214,000 | $1.91 | $409K | 214,000 |
| 2018-05-16 | Kocinsky Joseph Corp VP, CTO | Grant or award · Employee Stock Option (right to buy) | +214,000 | $1.91 | $409K | 214,000 |
| 2018-05-16 | Kendall David M Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +53,500 | $1.91 | $102K | 53,500 |
| 2018-05-16 | Barton Courtney Chief Compliance Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | $1.91 | $143K | 75,000 |
| 2018-05-16 | Alinaya Rosabel Realica SVP, Investor Relations | Grant or award · Employee Stock Option (right to buy) | +90,000 | $1.91 | $172K | 90,000 |
| 2018-05-16 | Binder Steven B. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +214,000 | $1.91 | $409K | 214,000 |
| 2018-05-16 | Castagna Michael Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +534,000 | $1.91 | $1.0M | 534,000 |
| 2018-02-28 | Alinaya Rosabel Realica SVP, Investor Relations | Shares withheld for taxes | −1,002 | $2.76 | $3K | 28,541 |
| 2018-02-21 | Kendall David M Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +180,100 | $2.76 | $497K | 180,100 |
| 2017-05-18 | Shannon James Samuel Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2017-05-18 | NORDHOFF HENRY L Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2017-05-18 | MacCallum David Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2017-05-18 | KRESA KENT Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 | ||
| 2017-05-18 | Friedman Michael A Director | Grant or award · Restricted Stock Unit | +65,200 | 65,200 |
Page 31 of 32 · 621 trades